381. A randomized controlled trial comparing the ventilation duration between adaptive support ventilation and pressure assist/control ventilation in medical patients in the ICU.
作者: Cenk Kirakli.;Ilknur Naz.;Ozlem Ediboglu.;Dursun Tatar.;Ahmet Budak.;Emel Tellioglu.
来源: Chest. 2015年147卷6期1503-1509页
Adaptive support ventilation (ASV) is a closed loop mode of mechanical ventilation (MV) that provides a target minute ventilation by automatically adapting inspiratory pressure and respiratory rate with the minimum work of breathing on the part of the patient. The aim of this study was to determine the effect of ASV on total MV duration when compared with pressure assist/control ventilation.
382. Understanding the Concept of Health Care-Associated Pneumonia in Lung Transplant Recipients.
作者: Federico Palacio.;Luis F Reyes.;Deborah J Levine.;Juan F Sanchez.;Luis F Angel.;Juan F Fernandez.;Stephanie M Levine.;Jordi Rello.;Ali Abedi.;Marcos I Restrepo.
来源: Chest. 2015年148卷2期516-522页
Limited data are available regarding the etiologic impact of health care-associated pneumonia (HCAP) in lung transplant recipients. Therefore, our aim was to evaluate the microbiologic differences between HCAP and hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) in lung transplant recipients with a radiographically confirmed diagnosis of pneumonia.
383. Palliative Care in Advanced Lung Disease: The Challenge of Integrating Palliation Into Everyday Care.
The tendency toward "either/or" thinking (either cure or comfort) in traditional biomedical care paradigms does little to optimize care in advancing chronic illness. Calls for improved palliation in chronic lung disease mandate a review of related care gaps and current clinical practices. Although specialist palliative services have their advocates, adding yet another element to an already fragmented, often complex, care paradigm can be a challenge. Instead, we propose a more holistic, patient-centered approach based on elements fundamental to palliative and best care practices generally and integrated as needed across the entire illness trajectory. To support this approach, we review the concept of primary palliative care competencies, identify vulnerability specific to those living with advanced COPD (an exemplar of chronic lung disease), and describe the need for care plans shaped by patient-centered communication, timely palliative responsiveness, and effective advance care planning. A costly systemic issue in the management of chronic lung disease is patients' increasing dependency on episodic ED care to deal with preventable episodic crises and refractory dyspnea. We address this issue as part of a proposed model of care that provides proactive, collaborative case management and the appropriate and carefully monitored use of opioids. We encourage and support a renewed primary care resolve to integrate palliative approaches to care in advanced lung disease that, in concert with judicious referral to appropriate specialist palliative care services, is fundamental to what should be a more sustainable systematic improvement in palliative care delivery.
384. Mechanical Ventilation and ARDS in the ED: A Multicenter, Observational, Prospective, Cross-sectional Study.
作者: Brian M Fuller.;Nicholas M Mohr.;Christopher N Miller.;Andrew R Deitchman.;Brian J Levine.;Nicole Castagno.;Elizabeth C Hassebroek.;Adam Dhedhi.;Nicholas Scott-Wittenborn.;Edward Grace.;Courtney Lehew.;Marin H Kollef.
来源: Chest. 2015年148卷2期365-374页
There are few data regarding mechanical ventilation and ARDS in the ED. This could be a vital arena for prevention and treatment.
385. Construct validity and minimal important difference of 6-minute walk distance in survivors of acute respiratory failure.
作者: Kitty S Chan.;Elizabeth R Pfoh.;Linda Denehy.;Doug Elliott.;Anne E Holland.;Victor D Dinglas.;Dale M Needham.
来源: Chest. 2015年147卷5期1316-1326页
The 6-min walk distance (6MWD), a widely used test of functional capacity, has limited evidence of construct validity among patients surviving acute respiratory failure (ARF) and ARDS. The objective of this study was to examine construct validity and responsiveness and estimate minimal important difference (MID) for the 6MWD in patients surviving ARF/ARDS.
386. The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysis.
作者: Brian M Fuller.;Nicholas M Mohr.;Lee Skrupky.;Susan Fowler.;Marin H Kollef.;Christopher R Carpenter.
来源: Chest. 2015年147卷6期1510-1522页
This study aimed to determine whether inhaled prostaglandins are associated with improvement in pulmonary physiology or mortality in patients with ARDS and assess adverse effects.
387. Intrapleural Fibrinolysis for the Treatment of Indwelling Pleural Catheter-Related Symptomatic Loculations: A Multicenter Observational Study.
作者: Rajesh Thomas.;Francesco Piccolo.;Daniel Miller.;Paul R MacEachern.;Alex C Chee.;Taha Huseini.;Lonny Yarmus.;Rahul Bhatnagar.;Hans J Lee.;David Feller-Kopman.;Nick A Maskell.;Alain Tremblay.;Y C Gary Lee.
来源: Chest. 2015年148卷3期746-751页
Indwelling pleural catheters (IPCs) are an effective option in the management of malignant pleural effusion. Up to 14% of patients with IPCs develop symptomatic pleural loculations causing ineffective fluid drainage and breathlessness. To our knowledge, this is the first study to describe intrapleural fibrinolytic therapy for IPC-related symptomatic loculations.
388. Complications Following Therapeutic Bronchoscopy for Malignant Central Airway Obstruction: Results of the AQuIRE Registry.
作者: David E Ost.;Armin Ernst.;Horiana B Grosu.;Xiudong Lei.;Javier Diaz-Mendoza.;Mark Slade.;Thomas R Gildea.;Michael Machuzak.;Carlos A Jimenez.;Jennifer Toth.;Kevin L Kovitz.;Cynthia Ray.;Sara Greenhill.;Roberto F Casal.;Francisco A Almeida.;Momen Wahidi.;George A Eapen.;Lonny B Yarmus.;Rodolfo C Morice.;Sadia Benzaquen.;Alain Tremblay.;Michael Simoff.; .
来源: Chest. 2015年148卷2期450-471页
There are significant variations in how therapeutic bronchoscopy for malignant airway obstruction is performed. Relatively few studies have compared how these approaches affect the incidence of complications.
389. Clinical Worsening as Composite Study End Point in Pediatric Pulmonary Arterial Hypertension.
作者: Mark-Jan Ploegstra.;Sanne Arjaans.;Willemljn M H Zijlstra.;Johannes M Douwes.;Theresia R Vissia-Kazemier.;Marcus T R Roofthooft.;Hans L Hillege.;Rolf M F Berger.
来源: Chest. 2015年148卷3期655-666页
Clinical worsening (CW), an increasingly used composite end point in adult pulmonary arterial hypertension (PAH), has not yet been evaluated in pediatric PAH. This study aims to evaluate the usefulness of CW in pediatric PAH by assessing the event incidence and prognostic value of each separate component of CW and of the composite CW end point.
390. Chronic Bronchitis Is Associated With Worse Symptoms and Quality of Life Than Chronic Airflow Obstruction.
作者: Paula M Meek.;Hans Petersen.;George R Washko.;Alejandro A Diaz.;Victor Klm.;Akshay Sood.;Yohannes Tesfaigzi.
来源: Chest. 2015年148卷2期408-416页
COPD includes the chronic bronchitis (CB) and emphysema phenotypes. Although it is generally assumed that emphysema or chronic airflow obstruction (CAO) is associated with worse quality of life (QOL) than is CB, this assumption has not been tested.
391. Tobacco Smoke Exposure, Airway Resistance, and Asthma in School-age Children: The Generation R Study.
作者: Herman T den Dekker.;Agnes M M Sonnenschein-van der Voort.;Johan C de Jongste.;Irwin K Reiss.;Albert Hofman.;Vincent W V Jaddoe.;Liesbeth Duijts.
来源: Chest. 2015年148卷3期607-617页
Tobacco smoke exposure has been associated with early childhood asthma symptoms. We assessed the associations of tobacco smoke exposure during pregnancy and childhood with wheezing patterns, asthma, airway interrupter resistance (Rint), and fractional exhaled nitric oxide (Feno) in school-age children and whether birth characteristics explained the associations.
392. Distractive Auditory Stimuli in the Form of Music in Individuals With COPD: A Systematic Review.
Music has been used as a distractive auditory stimulus (DAS) in patients with COPD, but its effects are unclear. This systematic review aimed to establish the effect of DAS on exercise capacity, symptoms, and health-related quality of life (HRQOL) under three conditions: (1) during exercise training, (2) during exercise testing, and (3) for symptom management at rest.
393. Standardizing Predicted Body Weight Equations for Mechanical Ventilation Tidal Volume Settings.
Recent recommendations for lung protective mechanical ventilation include a tidal volume target of 6 mL/kg predicted body weight (PBW). Different PBW equations might introduce important differences in tidal volumes delivered to research subjects and patients.
394. A 55-year-old man with a small right lung and a right-sided heart.
A healthy 55-year-old man without known medical problems presented for a routine physical examination and was found to have an abnormal ECG. He denied chest pain, dyspnea, palpitations, dizziness, or syncopal episodes. He also denied orthopnea, paroxysmal nocturnal dyspnea, and lower-extremity edema. His exercise capacity had been excellent. He was a lifelong nonsmoker and never had lung problems.
395. A 62-year-old man with skin rash and an abnormal chest radiograph.
作者: Tyler J Albert.;Sarah Bastawrous.;Gregory J Raugi.;Jan V Hirschmann.
来源: Chest. 2015年147卷3期e90-e94页
A 62-year-old man developed a scalp rash 2 months ago, followed by bilateral eyelid swelling. The nonpruritic rash then spread to involve most of his skin. He also had fatigue, muscle weakness, mild muscle soreness with activity, and dysphagia for solid foods for the last 3 weeks. He had no other symptoms. He had a 50 pack-year history of smoking and drank two to three shots of alcohol daily.
396. A 51-year-old man with seizures and progressive behavioral changes.
作者: Casey A Cable.;William D Freeman.;Mark N Rubin.;Andras Khoor.;Lioudmila V Karnatovskaia.
来源: Chest. 2015年147卷3期e86-e89页
A 51-year-old man was admitted for evaluation of new-onset generalized seizures in the context of progressive and significant behavioral change. His medical history was only notable for previous outbreaks of genital herpes. He took no medications. He had occasional social alcohol use and no illicit drug use but was a 35-pack-year current smoker. The patient had no relevant occupational exposure history but had recently traveled to Panama. Initially, the patient's significant other noticed a progressive flattening of his affect. The patient then started to experience episodes of "passing out" that led to injuries prompting ED visits. He was prescribed antiseizure medications and scheduled for an outpatient workup. However, with progressive gait instability, lethargy, and an increase in frequency of generalized seizures, the patient was admitted for treatment of suspected viral encephalitis. Despite initiation of antimicrobial and antiviral therapy, the patient's level of alertness continued to decline, ultimately leading to intubation for airway protection.
398. Improved clinical and radiographic outcomes after treatment with ivacaftor in a young adult with cystic fibrosis with the P67L CFTR mutation.
作者: Shatha Yousef.;George M Solomon.;Alan Brody.;Steven M Rowe.;Andrew A Colin.
来源: Chest. 2015年147卷3期e79-e82页
The underlying cause of cystic fibrosis (CF) is the loss of epithelial chloride and bicarbonate transport due to mutations in the CF transmembrane conductance regulator (CFTR) gene encoding the CFTR protein. Ivacaftor is a gene-specific CFTR potentiator that augments in vivo chloride transport in CFTR mutations affecting channel gating. Originally approved for the G511D CFTR mutation, ivacaftor is now approved for eight additional alleles exhibiting gating defects and has also been tested in R117H, a CFTR mutation with residual function that exhibits abnormal gating. P67L is a class 4 conductance (nongating) mutation exhibiting residual CFTR function. We report marked clinical improvement, normalization of spirometry, and dramatic reduction in radiographic structural airway changes after > 1 year of treatment with ivacaftor in a young adult with the compound heterozygous genotype P67L/F508del CFTR. The case suggests that ivacaftor may have a potential benefit for patients with CF with nongating mutations.
399. Hybrid DynaCT scan-guided localization single-port lobectomy. [corrected].
作者: Calvin S H Ng.;Cheuk Man Chu.;Micky W T Kwok.;Anthony P C Yim.;Randolph H L Wong.
来源: Chest. 2015年147卷3期e76-e78页
Small pulmonary lesions can be difficult to locate intraoperatively. Preoperative CT scan-guided localization, for example with hookwire, is a popular method to help localize such lesions. However, the delay between CT scan localization with hookwire and surgery can lead to risks of pneumothorax and wire dislodgement. We describe a 56-year-old woman who underwent DynaCT-guided hookwire localization of a ground-glass opacity in the hybrid operating room followed immediately by single-port video-assisted thoracic surgery lobectomy. The advantages, disadvantages, and special considerations in adopting this approach are discussed.
|